Mechanism of p53-dependent Tumor Suppression
Mechanism of p53-dependent Tumor Suppression
批准号:
10360506
负责人:
Xinbin Chen
金额:
$44.3万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-03-15 至 2025-03-31
关键词:
Aspartic AcidBindingBiologyCanis familiarisCell AgingCell LineCellsCessation of lifeChargeComplexDNA DamageDatabasesExposure toFeedbackGenesGenetic TranslationHealthHumanHydrogen BondingIn VitroKnock-inKnock-in MouseLarge Intestine CarcinomaLymphomaLysineMalignant NeoplasmsMediatingMessenger RNAModelingMolecularMusMutateMutationOncogenesPathway interactionsPeptidesPhosphorylationPlayPremature aging syndromeRNA-Binding ProteinsRegulationRoleSeriesSerineSignal TransductionStressTP53 geneTestingThe Cancer Genome AtlasTherapeuticTherapeutic AgentsTranslationsTumor SuppressionTumor-DerivedVariantbasecell growthin silicoin vivoin vivo Modelmalignant breast neoplasmmouse modelmutantneoplastic cellpreventresponsescreeningsensorsimulationtranscription factortumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
p53 tumor suppressor is frequently mutated in cancer, and mutant p53 is an oncogene. Upon exposure
to a stress signal, such as DNA damage, p53 transcription factor is activated and then induces an array of
pro-survival and pro-death genes. Among these is Rbm38, a RNA-binding protein. Interestingly, we
showed that Rbm38 represses p53 mRNA translation by preventing eIF4E from binding to p53 m7G cap.
Thus, p53 and Rbm38 constitutes a feedback loop. To determine the significance of the p53-Rbm38
loop, we showed that:(1) phosphorylation of serine-195 and substitution of S195 with aspartic acid
(S195D) prevent Rbm38 from interacting with eIF4E, which converts Rbm38 from a repressor to an
activator of p53 translation; (2) an 8-aa peptide derived from Rbm38 (Pep8: YPYAAS195PA) and a 23-
aa peptide derived from eIF4E (Pep23: aa 195-217) are able to disrupt the Rbm38-eIF4E complex to
increase p53 expression. These observations prompt us to hypothesize that the Rbm38-eIF4E pathway,
which is regulated by S195 phosphorylation and mutations in Rbm38, plays a critical role in p53-
mediated tumor suppression. To test this, we will determine: (1) how p53-dependent tumor suppression
is regulated by the Rbm38-eIF4E pathway; (2) whether the Rbm38-eIF4E pathway can be targeted to
kill tumor cells carrying wild-type p53.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Mechanism and Therapeutic Potential of Targeting the Ninjurin Pathway for Tumors Carrying Wild-Type p53
-
批准号:10501882
-
项目类别:
-
资助金额:$43.89万
-
财政年份:2022
-
负责人:Xinbin Chen
-
依托单位:
The Mechanism and Therapeutic Potential of Targeting the Ninjurin Pathway for Tumors Carrying Wild-Type p53
-
批准号:10650436
-
项目类别:
-
资助金额:$43.15万
-
财政年份:2022
-
负责人:Xinbin Chen
-
依托单位:
UC Davis DVM/PhD Medical Scientist Training Program
-
批准号:10641812
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2020
-
负责人:Xinbin Chen
-
依托单位:
UC Davis DVM/PhD Medical Scientist Training Program
-
批准号:10204049
-
项目类别:
-
资助金额:$24.02万
-
财政年份:2020
-
负责人:Xinbin Chen
-
依托单位:
Mechanism of p53-dependent Tumor Suppression
-
批准号:10574526
-
项目类别:
-
资助金额:$44.46万
-
财政年份:2020
-
负责人:Xinbin Chen
-
依托单位:
The feedback loop between ferredoxin reductase and the p53 family in tumor suppression
-
批准号:10330451
-
项目类别:
-
资助金额:$38.36万
-
财政年份:2018
-
负责人:Xinbin Chen
-
依托单位:
The role of the p63-RBM38 loop in tumor suppression
-
批准号:9244740
-
项目类别:
-
资助金额:$35.91万
-
财政年份:2016
-
负责人:Xinbin Chen
-
依托单位:
The role of the p63-RBM38 loop in tumor suppression
-
批准号:9904126
-
项目类别:
-
资助金额:$35.91万
-
财政年份:2016
-
负责人:Xinbin Chen
-
依托单位:
The role of the p63-RBM38 loop in tumor suppression
-
批准号:9118598
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2016
-
负责人:Xinbin Chen
-
依托单位:
The role of DNA polymerase eta in DNA damage response and p53 activation
-
批准号:8035416
-
项目类别:
-
资助金额:$27.77万
-
财政年份:2010
-
负责人:Xinbin Chen
-
依托单位:
The role of DNA polymerase eta in DNA damage response and p53 activation
-
批准号:8433258
-
项目类别:
-
资助金额:$26.22万
-
财政年份:2010
-
负责人:Xinbin Chen
-
依托单位:
The role of DNA polymerase eta in DNA damage response and p53 activation
-
批准号:8207293
-
项目类别:
-
资助金额:$27.86万
-
财政年份:2010
-
负责人:Xinbin Chen
-
依托单位:
The role of DNA polymerase eta in DNA damage response and p53 activation
-
批准号:7898966
-
项目类别:
-
资助金额:$28.57万
-
财政年份:2010
-
负责人:Xinbin Chen
-
依托单位:
The role of DNA polymerase eta in DNA damage response and p53 activation
-
批准号:8606823
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2010
-
负责人:Xinbin Chen
-
依托单位:
Regulation of Mutant P53 Expression and Oncogenic Activity
-
批准号:8676449
-
项目类别:
-
资助金额:$27.44万
-
财政年份:2007
-
负责人:Xinbin Chen
-
依托单位:
Molecular Oncogenic Properties of Mutant p53
-
批准号:7994858
-
项目类别:
-
资助金额:$28.01万
-
财政年份:2007
-
负责人:Xinbin Chen
-
依托单位:
Regulation of Mutant P53 Expression and Oncogenic Activity
-
批准号:8520202
-
项目类别:
-
资助金额:$26.6万
-
财政年份:2007
-
负责人:Xinbin Chen
-
依托单位:
Molecular Oncogenic Properties of Mutant p53
-
批准号:7391038
-
项目类别:
-
资助金额:$28.85万
-
财政年份:2007
-
负责人:Xinbin Chen
-
依托单位:
Regulation of Mutant P53 Expression and Oncogenic Activity
-
批准号:8391661
-
项目类别:
-
资助金额:$28.38万
-
财政年份:2007
-
负责人:Xinbin Chen
-
依托单位:
Molecular Oncogenic Properties of Mutant p53
-
批准号:7212503
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:Xinbin Chen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: